Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
4 "diabetes complications"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Articles
Estimation of the onset time of diabetic complications in type 2 diabetes patients in Thailand: a survival analysis
Natthanicha Sauenram, Jutatip Sillabutra, Chukiat Viwatwongkasem, Pratana Satitvipawee
Osong Public Health Res Perspect. 2023;14(6):508-519.   Published online November 23, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.0084
  • 1,057 View
  • 61 Download
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
This study aimed to identify factors associated with the onset time of diabetic complications in patients with type 2 diabetes mellitus (T2DM) and determine the best-fitted survival model. Methods: A retrospective cohort study was conducted among T2DM patients enrolled from October 1, 2016 to July 15, 2020 at the National Health Security Office (NHSO). In total, 388 T2DM patients were included. Cox proportional-hazard and parametric models were used to identify factors related to the onset time of diabetic complications. The Akaike information criterion, Bayesian information criterion, and Cox-Snell residual were compared to determine the best-fitted survival model. Results: Thirty diabetic complication events were detected among the 388 patients (7.7%). A 90% survival rate for the onset time of diabetic complications was found at 33 months after the first T2DM diagnosis. According to multivariate analysis, a duration of T2DM ≥42 months (time ratio [TR], 0.56; 95% confidence interval [CI], 0.33–0.96; p=0.034), comorbid hypertension (TR, 0.30; 95% CI, 0.15–0.60; p=0.001), mildly to moderately reduced levels of the estimated glomerular filtration rate (eGFR) (TR, 0.43; 95% CI, 0.24–0.75; p=0.003) and an eGFR that was severely reduced or indicative of kidney failure (TR, 0.38; 95% CI, 0.16–0.88; p=0.025) were significantly associated with the onset time of diabetic complications (p<0.05). Conclusion: Patients with T2DM durations of more than 42 months, comorbid hypertension, and decreased eGFR were at risk of developing diabetic complications. The NHSO should be aware of these factors to establish a policy to prevent diabetic complications after the diagnosis of T2DM.
Educational Needs Associated with the Level of Complication and Comparative Risk Perceptions in People with Type 2 Diabetes
Youngji Hwang, Dongsuk Lee, Yeon Sook Kim
Osong Public Health Res Perspect. 2020;11(4):170-176.   Published online August 31, 2020
DOI: https://doi.org/10.24171/j.phrp.2020.11.4.05
  • 5,166 View
  • 157 Download
AbstractAbstract PDF
Objectives

This study aimed to identify the educational needs of people with type 2 diabetes according to risk perceptions and the level of severity of complications.

Methods

There were 177 study participants who were outpatients of the internal medicine department at a university hospital located in the Republic of Korea, who consented to participate in the survey from December 10, 2016 to February 10, 2017. The data were analyzed using descriptive statistics, Pearson correlation, ANOVA with post-hoc comparison, and multiple regression analysis. Type 2 diabetes complications were classified into 3 groups: no complications, common complications, and severe complications.

Results

There were statistically significant positive correlations between educational needs and comparative risk perceptions, and the level of complication and comparative risk perception. Multiple regression analysis revealed that the factor predicting educational needs of type 2 diabetes people was their comparative risk perceptions, rather than the severity of diabetes complications or sociodemographic variables.

Conclusion

Since risk perception is the factor that indicates the educational needs of people with type 2 diabetes, there is a need to explore factors which increase risk perception, in order to meet educational needs. The findings suggest that a more specific and individualized educational program, which focuses on each person's risk perceptions, should be developed.

Factors that Correlate with Poor Glycemic Control in Type 2 Diabetes Mellitus Patients with Complications
Mohammad Haghighatpanah, Amir Sasan Mozaffari Nejad, Maryam Haghighatpanah, Girish Thunga, Surulivelrajan Mallayasamy
Osong Public Health Res Perspect. 2018;9(4):167-174.   Published online August 31, 2018
DOI: https://doi.org/10.24171/j.phrp.2018.9.4.05
  • 8,681 View
  • 153 Download
  • 55 Crossref
AbstractAbstract PDF
Objectives

Inadequate glycemic control amongst patients with Type 2 diabetes mellitus (T2DM) indicates a major public health problem and a significant risk factor for the progression and complications caused by diabetes. Glycemic control is the main therapeutic objective for the prevention of organ damage and other complications arising from diabetes.

Methods

This was a retrospective observational study of T2DM patients with complications, who were aged 40 years and older. The study was conducted retrospectively on medical records (in-patient and out-patient) obtained from a South Indian teaching hospital, Manipal, India. The patients included in the study had fasting blood sugar, postprandial blood sugar and HbA1c measured at least twice during follow-ups the previous year. Patients’ HbA1c levels were categorized into good control ≤7% (≤53mmol/mol), and poor control >7% (>53mmol/mol), and patients’ characteristics were analyzed.

Results

A total of 657 patients were included in the study. The mean age was 59.67 (SD = 9.617) years, with 152 (23.1%) females and 505 (76.9%) males, and 514 (78.2%) patients had poor glycemic control. Most of the patients were on insulin mono-therapy [n = 271 (42.1%)], about a third of the patients were on combination therapy that included an oral hypoglycemic agent and insulin [n = 236 (36.6%)]. Patients with a history of more than 10 years of diabetes [n = 293 (44.6%)], had a family history of diabetes [n = 256 (39%)] and obesity [n = 95 (14.5%)], all had poor glycemic control.

Conclusion

This present study indicated a significant association of gender (female), age, high-density lipoprotein level, duration of diabetes and type of medication, with poor glycemic control in T2DM patients that had secondary medical complications.

Citations

Citations to this article as recorded by  
  • Effectiveness of Family-Based Diabetes Management Intervention on Glycated Haemoglobin Among Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Margareta Teli, Ratsiri Thato, Faizul Hasan, Yohanes Andy Rias
    Biological Research For Nursing.2024; 26(2): 315.     CrossRef
  • Factors linked to poor glycemic control in an outpatient diabetic clinic: a cross-sectional study in Saint-Nicolas Hospital, Haiti
    Ludentz Dorcélus, Emmanuel R. Alexandre, Charnee M. Villemenay, Scaïde U. Benjaminel, Eddie Charles
    Journal of Global Health Reports.2024;[Epub]     CrossRef
  • The prevalence of hypogonadism in male patients with type 2 diabetes mellitus and clinically relevant factors
    Hakan DÜĞER
    Journal of Health Sciences and Medicine.2024; 7(1): 53.     CrossRef
  • Real-world effectiveness of iGlarLixi in individuals with T2D sub-optimally controlled on oral anti-diabetic drugs with or without basal insulin in daily practice in Saudi Arabia (EMPOWER study)
    Anwar Jammah, Nagwa Roushdy, Mohamed Gamil, Nidal Abu Diab, Naglaa Abdelmonaem, Saher Safarini, Mohamed Gadallah, Nedal Abu Zaid, Yahya Shihadeh, Mohamed Saeed, Jamaa Sadik, Yasser Akil
    Endocrine and Metabolic Science.2024; 15: 100164.     CrossRef
  • Rejuvenating Mobility: Impact of Concurrent Exercise on Functional Claudication Distance and Vascular Health among Patients with T2DM-Associated PAD
    Uroosa Amin, Qurat-ul-Ain Adnan, Dr. Tauseef Ahmad
    Allied Medical Research Journal.2024; : 138.     CrossRef
  • Exploring the Interplay of Socioeconomic and Behavioral Factors: Unraveling Gender Disparities in Glycemic Control Among Adult Type 2 Diabetic Patients in Outpatient Care
    Amar Mankar, Umesh Kawalkar, Nilesh Jadhao, Umesh Joge, Ashutosh Paldiwal, Manoj Talapalliwar, Manoj S Patil
    Cureus.2024;[Epub]     CrossRef
  • Landscape of pharmacogenetic variants associated with non-insulin antidiabetic drugs in the Indian population
    Ambily Sivadas, S Sahana, Bani Jolly, Rahul C Bhoyar, Abhinav Jain, Disha Sharma, Mohamed Imran, Vigneshwar Senthivel, Mohit Kumar Divakar, Anushree Mishra, Arpita Mukhopadhyay, Greg Gibson, KM Venkat Narayan, Sridhar Sivasubbu, Vinod Scaria, Anura V Kurp
    BMJ Open Diabetes Research & Care.2024; 12(2): e003769.     CrossRef
  • Determinants of poor glycemic control among type 2 diabetes mellitus patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: Unmatched case-control study
    Gebrehiwot Lema Legese, Getahun Asres, Shitaye Alemu, Tesfaye Yesuf, Yeabsira Aklilu Tesfaye, Tsegaw Amare
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Prevalence of Glycemic Control and Factors Associated With Poor Glycemic Control: A Systematic Review and Meta-analysis
    Zebenay Workneh Bitew, Ayinalem Alemu, Desalegn Abebaw Jember, Erkihun Tadesse, Fekadeselassie Belege Getaneh, Awole Seid, Misrak Weldeyonnes
    INQUIRY: The Journal of Health Care Organization, .2023; 60: 004695802311557.     CrossRef
  • Glycemic control and diabetes complications among adult type 2 diabetic patients at public hospitals in Hadiya zone, Southern Ethiopia
    Abraham Lomboro Dimore, Zerihun Kura Edosa, Asmelash Abera Mitiku, Suman S. Thakur
    PLOS ONE.2023; 18(3): e0282962.     CrossRef
  • Using Machine Learning for the Risk Factors Classification of Glycemic Control in Type 2 Diabetes Mellitus
    Yi-Ling Cheng, Ying-Ru Wu, Kun-Der Lin, Chun-Hung Lin, I-Mei Lin
    Healthcare.2023; 11(8): 1141.     CrossRef
  • Knowledge and Awareness About Diabetes Mellitus Among Urban and Rural Population Attending a Tertiary Care Hospital in Haryana
    Dr.Lalit Kumar, Rahul Mittal, Akhil Bhalla, Ashwani Kumar, Hritik Madan , Kushagra Pandhi, Yukta Garg, Kamaldeep Singh, Arpit Jain, Surya Rana
    Cureus.2023;[Epub]     CrossRef
  • Glycemic Control and Its associated Determinants among Type II Diabetic Patients at Tertiary Care Hospital in North India
    Soorvir singh Gurger, Anshu Mittal, Gauri shankar Goel, Anuj Mittal, Deepmala Kamboj
    Healthline.2023; 14(1): 17.     CrossRef
  • Prevalence of medication adherence and glycemic control among patients with type 2 diabetes and influencing factors: A cross-sectional study
    Budi Suprapti, Zamrotul Izzah, Ade Giriayu Anjani, Mareta Rindang Andarsari, Wenny Putri Nilamsari, Cahyo Wibisono Nugroho
    Global Epidemiology.2023; 5: 100113.     CrossRef
  • The impact of pharmacist interventions, follow-up frequency and default on glycemic control in Diabetes Medication Therapy Adherence Clinic program: a multicenter study in Malaysia
    Phei Ching Lim, Hooi Hoon Tan, Nurul Ain Mohd Noor, Chee Tao Chang, Te Ying Wong, Ee Linn Tan, Chiou Ting Ong, Kalyhani Nagapa, Lee Shyong Tai, Wei Ping Chan, Yong Boey Sin, Yin Shan Tan, Shanty Velaiutham, Rohaizan Mohd Hanafiah
    Journal of Pharmaceutical Policy and Practice.2023;[Epub]     CrossRef
  • Early detection system of risk factors for diabetes mellitus type 2 utilization of machine learning-random forest
    Johannes B. Ginting, Tri Suci, Chrismis N. Ginting, Ermi Girsang
    Journal of Family and Community Medicine.2023; 30(3): 171.     CrossRef
  • Identifying Profiles of Patients With Uncontrolled Type 2 Diabetes Who Would Benefit From Referral to an Endocrinologist
    Eden Avnat, Gabriel Chodick, Varda Shalev
    Endocrine Practice.2023; 29(11): 855.     CrossRef
  • Glycemic control and associated factors among type 2 diabetes mellitus patients: a cross-sectional study of Azar cohort population
    Masoud Faghieh Dinavari, Sarvin Sanaie, Kimia Rasouli, Elnaz Faramarzi, Roghayeh Molani-Gol
    BMC Endocrine Disorders.2023;[Epub]     CrossRef
  • Metabolic Biomarkers in Adults with Type 2 Diabetes: The Role of PPAR-γ2 and PPAR-β/δ Polymorphisms
    Sandra A. Reza-López, Susana González-Gurrola, Oscar O. Morales-Morales, Janette G. Moreno-González, Ana M. Rivas-Gómez, Everardo González-Rodríguez, Verónica Moreno-Brito, Angel Licón-Trillo, Irene Leal-Berumen
    Biomolecules.2023; 13(12): 1791.     CrossRef
  • Estimation of the onset time of diabetic complications in type 2 diabetes patients in Thailand: a survival analysis
    Natthanicha Sauenram, Jutatip Sillabutra, Chukiat Viwatwongkasem, Pratana Satitvipawee
    Osong Public Health and Research Perspectives.2023; 14(6): 508.     CrossRef
  • What drives glycemic control in a person living with diabetes?
    Rajiv Singla, Geetu Gupta, Yashdeep Gupta
    International Journal of Diabetes in Developing Co.2022; 42(2): 369.     CrossRef
  • Prevalence and predictors of suboptimal glycemic control among patients with type 2 diabetes mellitus in northern Thailand: A hospital-based cross-sectional control study
    Fartima Yeemard, Peeradone Srichan, Tawatchai Apidechkul, Naphat Luerueang, Ratipark Tamornpark, Suphaphorn Utsaha, Sompop Bencharit
    PLOS ONE.2022; 17(1): e0262714.     CrossRef
  • Exploring of Determinants Factors of Anti-Diabetic Medication Adherence in Several Regions of Asia – A Systematic Review
    Much Ilham Novalisa Aji Wibowo, Nanang Munif Yasin, Susi Ari Kristina, Yayi Suryo Prabandari
    Patient Preference and Adherence.2022; Volume 16: 197.     CrossRef
  • Visual impairment and its predictors among people living with type 2 diabetes mellitus at Dessie town hospitals, Northeast Ethiopia: institution-based cross-sectional study
    Mohammed Abdu Seid, Adugnaw Ambelu, Mengistie Diress, Yigizie Yeshaw, Yonas Akalu, Baye Dagnew
    BMC Ophthalmology.2022;[Epub]     CrossRef
  • Relations of Well-Being, Coping Styles, Perception of Self-Influence on the Diabetes Course and Sociodemographic Characteristics with HbA1c and BMI Among People with Advanced Type 2 Diabetes Mellitus
    Agnieszka Łukasiewicz, Andrzej Kiejna, Ewelina Cichoń, Aleksandra Jodko-Modlińska, Marcin Obrębski, Andrzej Kokoszka
    Diabetes, Metabolic Syndrome and Obesity: Targets .2022; Volume 15: 407.     CrossRef
  • A bibliometric analysis of highly cited insulin resistance publications in Science Citation Index Expanded
    Yuh-Shan Ho, Priyanga Ranasinghe
    Obesity Medicine.2022; 31: 100399.     CrossRef
  • Alternate-day add-on therapy with dapagliflozin in patients with type 2 diabetes mellitus: potential benefits and concerns
    Harmanjit Singh, Dinesh Joshi, Seerat Narula, Mandeep Singla, Ravi Rohilla, Jagjit Singh
    Expert Review of Clinical Pharmacology.2022; 15(2): 197.     CrossRef
  • Factors associated with Glycemic control among Syrian patients with Type 2 Diabetes Mellitus
    Khadija Khalil, Afraa Zrieki`
    Research Journal of Pharmacy and Technology.2022; : 1701.     CrossRef
  • A Comparative analysis of type 2 diabetes management quality indicators in cancer survivors
    Eun J. Ko, Su J. Lee
    Asia-Pacific Journal of Oncology Nursing.2022; 9(11): 100116.     CrossRef
  • Analysis of the Association between Metabolic Syndrome and Renal Function in Middle-Aged Patients with Diabetes
    Yoonjin Park, Su Jung Lee
    International Journal of Environmental Research an.2022; 19(18): 11832.     CrossRef
  • Effective data-driven precision medicine by cluster-applied deep reinforcement learning
    Sang Ho Oh, Su Jin Lee, Jongyoul Park
    Knowledge-Based Systems.2022; 256: 109877.     CrossRef
  • Management goal achievements of diabetes care in Iran: study profile and main findings of DiaCare survey
    Gita Shafiee, Safoora Gharibzadeh, Nekoo Panahi, Farideh Razi, Seyed Masoud Arzaghi, Vahid Haghpanah, Afshin Ostovar, Alireza Raeisi, Alireza Mahdavi-Hezareh, Bagher Larijani, Ensieh Nasli Esfahani, Ramin Heshmat
    Journal of Diabetes & Metabolic Disorders.2022; 22(1): 355.     CrossRef
  • Glycemic control and its determinants among people with type 2 diabetes mellitus in Ernakulam district, Kerala
    ShanaShirin Najeeb, TeenaMary Joy, Aswathy Sreedevi, K Vijayakumar
    Indian Journal of Public Health.2022; 66(5): 80.     CrossRef
  • Sex Differences in the Effects of CDKAL1 Variants on Glycemic Control in Diabetic Patients: Findings from the Korean Genome and Epidemiology Study
    Hye Ah Lee, Hyesook Park, Young Sun Hong
    Diabetes & Metabolism Journal.2022; 46(6): 879.     CrossRef
  • Relationship and influences of behavioral and psychological factors on metabolic control of patients with type 2 diabetes mellitus
    Vojislav Stanojevic, Marija Jevtic, Milena Mitrovic, Marko Panajotovic, Aleksandar Aleksic, Cedomirka Stanojevic
    Vojnosanitetski pregled.2022; 79(12): 1177.     CrossRef
  • Lipid Profile and Glycemic Control in Type 2 Diabetic Patients
    Sarah Maan AL-Bahrani, Batool A.Gh. Yassin
    Arab Board Medical Journal.2022; 23(1): 21.     CrossRef
  • Glycemic Control of Diabetes Mellitus Patients in Referral Hospitals of Amhara Region, Ethiopia: A Cross-Sectional Study
    Berhanu Elfu Feleke, Teferi Elfu Feleke, Melkamu Beyene Kassahun, Wondemu Gebrekirose Adane, Netsanet Fentahun, Abel Girma, Alamirew Alebachew, Eyaya Misgan, Hanna Demelash Desyibelew, Mulat Tirfie Bayih, Omer Seid, Daniel Diaz
    BioMed Research International.2021; 2021: 1.     CrossRef
  • Association of glycemic control and anthropometric measurement among type 2 diabetes mellitus: a cross-sectional study
    Mitku Mammo Taderegew, Mamo Solomon Emeria, Betregiorgis Zegeye
    Diabetology International.2021; 12(4): 356.     CrossRef
  • Impact of pharmacist-led educational intervention on predictors of diabetic foot at two different hospitals of Malaysia
    AmerHayat Khan, MuhammadZahid Iqbal, SyedAzhar Syed Sulaiman, Aznita Ibrahim, NorShaffinaz Binti Yusoff Azmi, MuhammadShahid Iqbal, AhmedA Albassam
    Journal of Pharmacy And Bioallied Sciences.2021; 13(1): 108.     CrossRef
  • Factors Associated with Glycaemic Control among Diabetic Patients Managed at an Urban Hospital in Hanoi, Vietnam
    Luu Quang Thuy, Hoang Thi Phuong Nam, Tran Thi Ha An, Bui Van San, Tran Nguyen Ngoc, Le Hong Trung, Pham Huy Tan, Nguyen Hoang Thanh, Everson A Nunes
    BioMed Research International.2021; 2021: 1.     CrossRef
  • Predictors of Poor Plasma Glucose Maintenance in Type II Diabetic People with Ophthalmic Complication: The Case of Dessie Hospitals in Ethiopia
    Mohammed Abdu Seid, Baye Dagnew
    Diabetes, Metabolic Syndrome and Obesity: Targets .2021; Volume 14: 2317.     CrossRef
  • Oral health and longitudinal changes in fasting glucose levels: A nationwide cohort study
    Tae-Jin Song, Yoonkyung Chang, Jimin Jeon, Jinkwon Kim, David M. Ojcius
    PLOS ONE.2021; 16(6): e0253769.     CrossRef
  • Poor Glycemic Control and Its Contributing Factors Among Type 2 Diabetes Patients at Adama Hospital Medical College in East Ethiopia
    Tewodros Yosef, Dejen Nureye, Eyob Tekalign
    Diabetes, Metabolic Syndrome and Obesity: Targets .2021; Volume 14: 3273.     CrossRef
  • Probucol Pharmacological and Bio-Nanotechnological Effects on Surgically Transplanted Graft Due to Powerful Anti-Inflammatory, Anti-Fibrotic and Potential Bile Acid Modulatory Actions
    Armin Mooranian, Corina Mihaela Ionescu, Susbin Raj Wagle, Bozica Kovacevic, Daniel Walker, Melissa Jones, Jacqueline Chester, Thomas Foster, Edan Johnston, Momir Mikov, Marcus D. Atlas, Hani Al-Salami
    Pharmaceutics.2021; 13(8): 1304.     CrossRef
  • Clinical pharmacists education and counselling in patients with co-morbid hypertension and diabetes in a Municipal hospital in Ghana
    A. O. Kwakye, K. O. Buabeng, N. A. M. Opare-Addo, E. Owusu-Dabo
    African Journal of Pharmacy and Pharmacology.2021; 15(10): 183.     CrossRef
  • Effect of educational interventions on knowledge of the disease and glycaemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials
    Wondimeneh Shibabaw Shiferaw, Tadesse Yirga Akalu, Melaku Desta, Ayelign Mengesha Kassie, Pammla Margaret Petrucka, Yared Asmare Aynalem
    BMJ Open.2021; 11(12): e049806.     CrossRef
  • Persistent Cardiometabolic Health Gaps: Can Therapeutic Care Gaps Be Precisely Identified from Electronic Health Records
    Xiaowei Yan, Walter F. Stewart, Hannah Husby, Jake Delatorre-Reimer, Satish Mudiganti, Farah Refai, Andrew Hudnut, Kevin Knobel, Karen MacDonald, Frangiscos Sifakis, James B. Jones
    Healthcare.2021; 10(1): 70.     CrossRef
  • Glycemic control and awareness of foot care indiabetic foot syndrome
    Ayten Guner Atayoglu, Ali Timucin Atayoglu, Rahime Ozgur, Hammad Khan
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(3): 200.     CrossRef
  • Раннє призначення інсуліну при цукровому діабеті 2-го типу: плюси і мінуси
    S.V. Jargin
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(2): 169.     CrossRef
  • Salutogenic model of health to identify turning points and coping styles for eating practices in type 2 diabetes mellitus
    C. M. M. Polhuis, L. Vaandrager, S. S. Soedamah-Muthu, M. A. Koelen
    International Journal for Equity in Health.2020;[Epub]     CrossRef
  • Self-Care in Adults with Type 2 Diabetes Mellitus: A Systematic Review
    Rebeca Barbosa da Rocha, Cristiano Sales Silva, Vinícius Saura Cardoso
    Current Diabetes Reviews.2020; 16(6): 598.     CrossRef
  • Medication adherence assessment among patients with type 2 diabetes mellitus treated polytherapy in indonesian community health center: A cross sectional-study
    Nora Wulandari, Maifitrianti Maifitrianti, Faridlatul Hasanah, Sri Atika, Risa Dini Putri
    Journal of Pharmacy And Bioallied Sciences.2020; 12(6): 758.     CrossRef
  • Glycemic Control Among People Living with Diabetes and Human Immunodeficiency Virus in Ethiopia: Leveraging Clinical Care for the Looming  Co-Epidemics


    Tsegaye Melaku, Legese Chelkeba, Zeleke Mekonnen, Kabaye Kumela
    Diabetes, Metabolic Syndrome and Obesity: Targets .2020; Volume 13: 4379.     CrossRef
  • Electronic medical records-based comparison of glycemic control efficacy between sulfonylureas and dipeptidyl peptidase-4 inhibitors added on to metformin monotherapy in patients with type 2 diabetes
    Suhrin Lee, SeungHwan Lee, In-Jin Jang, Kyung-Sang Yu, Su-jin Rhee
    Translational and Clinical Pharmacology.2020; 28(4): 199.     CrossRef
  • Poor-Glycaemic-Control Prevalence and Determinants among Type 2 Diabetes Mellitus Patients Attending a Primary Health Care Setting in Central Kerala
    Sajith Kumar Soman, Binu Areekal, Sudhiraj Thiruthara Sukumaran, Safa Puliyakkadi, Rajesh Koothupalakkal Ravi
    Journal of Evidence Based Medicine and Healthcare.2020; 7(49): 2892.     CrossRef
Brief Report
Imported Melioidosis in South Korea: A Case Series with a Literature Review
Seung Woo Kim, Geun-Yong Kwon, Bongyoung Kim, Donghyok Kwon, Jaeseung Shin, Geun-Ryang Bae
Osong Public Health Res Perspect. 2015;6(6):363-368.   Published online December 31, 2015
DOI: https://doi.org/10.1016/j.phrp.2015.10.014
  • 2,838 View
  • 18 Download
  • 12 Crossref
AbstractAbstract PDF
Objectives
Melioidosis is a potentially fatal infectious disease caused by the environmental anaerobic Gram-negative bacillus Burkholderia pseudomallei. Melioidosis is endemic to areas of northern Australia and Southeast Asia. With increasing international travel and migration, imported cases of melioidosis are being reported regularly. Here, we summarize the 11 cases of melioidosis reported in South Korea from 2003 to 2014.
Methods
Tracing epidemiological investigations were performed on every patient reported to the National Surveillance System since 2011. A systematic literature search was performed to identify melioidosis cases that occurred prior to 2011.
Results
The overall fatality rate was 36.4%. All the patients had visited Southeast Asia where melioidosis is endemic. The stay in the endemic region ranged from 4 days to 20 years. Of the seven patients who developed initial symptoms after returning to South Korea, the time interval between returning to South Korea and symptom onset ranged from 1 day to 3 years. The remaining four patients developed symptoms during their stay in the endemic region and were diagnosed with melioidosis in South Korea. Seven (63.6%) patients possessed at least one risk factor, all of whom were diabetic. Pneumonia was the most frequent clinical manifestation, but the patients showed a wide spectrum of clinical features, including internal organ abscesses, a mycotic aneurysm of the aorta, and coinfection with tuberculosis.
Conclusion
An early diagnosis and initiation of the appropriate antibiotics can reduce the mortality of melioidosis. Consequently, increased awareness of the risk factors and clinical features of melioidosis is required.

Citations

Citations to this article as recorded by  
  • An overview of the study designs and statistical methods used in the determination of predictors of melioidosis mortality in Malaysia: 2010-2021
    Kamaruddin Mardhiah, Othman Nursyahiyatul-Anis
    Pedagogical Research.2024; 9(3): em0205.     CrossRef
  • Epidemiological Aspects of Imported Melioidosis in Korea and Japan, 2011 to 2020
    Myeong-Jin Lee, Kyu Sung Kim, Won-Chang Lee, Young Hwan Kwon
    The Korean Journal of Aerospace and Environmental .2023; 33(1): 32.     CrossRef
  • The Cox model of predicting mortality among melioidosis patients in Northern Malaysia
    Kamaruddin Mardhiah, Nadiah Wan-Arfah, Nyi Nyi Naing, Muhammad Radzi Abu Hassan, Huan-Keat Chan
    Medicine.2021; 100(25): e26160.     CrossRef
  • Tuberculosis and Melioidosis at Distinct Sites Occurring Simultaneously
    Seow Yen Tan
    Case Reports in Infectious Diseases.2020; 2020: 1.     CrossRef
  • Burkholderia pseudomallei pathogenesis and survival in different niches
    Chee-Hoo Yip, Ahmad-Kamal Ghazali, Sheila Nathan
    Biochemical Society Transactions.2020; 48(2): 569.     CrossRef
  • Mycotic aneurysm secondary to melioidosis in China: A series of eight cases and a review of literature
    Hua Wu, Xuming Wang, Xiaojun Zhou, Zhicheng Wu, Yanyan Wang, Mengjie Pan, Binghuai Lu, Susanna Jane Dunachie
    PLOS Neglected Tropical Diseases.2020; 14(8): e0008525.     CrossRef
  • Fatal deep venous thrombosis and pulmonary embolism secondary to melioidosis in China: case report and literature review
    Hua Wu, Dongliang Huang, Biao Wu, Mengjie Pan, Binghuai Lu
    BMC Infectious Diseases.2019;[Epub]     CrossRef
  • Melioidosis in the Philippines
    Peter San Martin, Joseph Chua, Ralph Bautista, Jennifer Nailes, Mario Panaligan, David Dance
    Tropical Medicine and Infectious Disease.2018; 3(3): 99.     CrossRef
  • Clinical and Imaging Findings of Musculoskeletal Melioidosis in the Right Hip: A Case Report
    Myung Hyun Kim, Tong Jin Chun
    Journal of the Korean Society of Radiology.2018; 78(3): 212.     CrossRef
  • Draft Genome Sequence of the First South Korean Clinical Isolate of Burkholderia pseudomallei, H0901
    Yong-Woo Shin, Myung-Min Choi, Jeong-Hoon Chun, Jae-Yon Yu, Dae-Won Kim, Gi-eun Rhie
    Genome Announcements.2018;[Epub]     CrossRef
  • Accidental Occupational Exposure to Burkholderia pseudomallei in South Korea Did Not Result in Melioidosis
    Jae-Bum Jun, Taehoon Lee, Joseph Jeong, Jeong-Hoon Chun, Yong-Woo Shin, Jiwon Jung
    Infection Control & Hospital Epidemiology.2017; 38(7): 886.     CrossRef
  • Molecular detection of leptospirosis and melioidosis co-infection: A case report
    Mohammad R. Mohd Ali, Amira W. Mohamad Safiee, Padmaloseni Thangarajah, Mohd H. Fauzi, Alwi Muhd Besari, Nabilah Ismail, Chan Yean Yean
    Journal of Infection and Public Health.2017; 10(6): 894.     CrossRef

PHRP : Osong Public Health and Research Perspectives